|
Volumn 280, Issue 5366, 1998, Pages 996-997
|
The power of the front page of The New York Times
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOSTATIN;
ANTINEOPLASTIC AGENT;
ENDOSTATIN;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
BLINDNESS;
CANCER CONTROL;
CANCER RESEARCH;
DRUG INFORMATION;
DRUG MECHANISM;
MOUSE;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PUBLICATION;
TUMOR VASCULARIZATION;
ANGIOSTATINS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
COLLAGEN;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
ENDOSTATINS;
HUMANS;
INVESTMENTS;
JOURNALISM, MEDICAL;
MICE;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
NEWSPAPERS;
PEPTIDE FRAGMENTS;
PLASMINOGEN;
ANIMALIA;
|
EID: 0032524068
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.280.5366.996 Document Type: Note |
Times cited : (31)
|
References (0)
|